18-77250600-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001480.4(GALR1):c.52C>T(p.Pro18Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000816 in 1,555,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001480.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GALR1 | NM_001480.4 | c.52C>T | p.Pro18Ser | missense_variant | 1/3 | ENST00000299727.5 | |
LOC124904329 | XR_007066422.1 | n.604+248G>A | intron_variant, non_coding_transcript_variant | ||||
GALR1 | XM_017025691.2 | c.52C>T | p.Pro18Ser | missense_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GALR1 | ENST00000299727.5 | c.52C>T | p.Pro18Ser | missense_variant | 1/3 | 1 | NM_001480.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000486 AC: 74AN: 152158Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000119 AC: 19AN: 159460Hom.: 0 AF XY: 0.0000802 AC XY: 7AN XY: 87290
GnomAD4 exome AF: 0.0000378 AC: 53AN: 1403548Hom.: 0 Cov.: 36 AF XY: 0.0000317 AC XY: 22AN XY: 694384
GnomAD4 genome AF: 0.000486 AC: 74AN: 152274Hom.: 0 Cov.: 34 AF XY: 0.000484 AC XY: 36AN XY: 74454
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 20, 2023 | The c.52C>T (p.P18S) alteration is located in exon 1 (coding exon 1) of the GALR1 gene. This alteration results from a C to T substitution at nucleotide position 52, causing the proline (P) at amino acid position 18 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
GALR1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 08, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at